Abstract:<h3 class="a-plus-plus">Abstract</h3> <p class="a-plus-plus">Tau is an axonal microtubule-binding protein. Tau pathology in brain and increased tau concentration in the cerebrospinal fluid (CSF) are hallmarks of Alzheimer’s disease (AD). Most of tau in CSF is present as fragments. We immunoprecipitated tau from CSF and identified several endogenous peptides ending at amino acid (aa) 123 or 224 using high-resolution mass spectrometry. We raised neo-epitope-specific antibodies against tau fragments specifically ending at aa 123 and 224, respectively. With these antibodies, we performed immunohistochemistry on brain tissue and designed immunoassays measuring N-123, N-224, and x-224 tau. Immunoassays were applied to soluble brain fractions from pathologically confirmed subjects (81 AD patients, 33 controls), CSF from three cross-sectional and two longitudinal cohorts (a total of 133 AD, 38 MCI, 20 MCI-AD, 31 PSP, 15 CBS patients, and 91 controls), and neuronally- and peripherally-derived extracellular vesicles (NDEVs and PDEVs, respectively) in serum from four AD patients and four controls. Anti-tau 224 antibody stained neurofibrillary tangles and neuropil threads, while anti-tau 123 only showed weak cytoplasmic staining in AD. N-224 tau was lower in the AD soluble brain fraction compared to controls, while N-123 tau showed similar levels. N-224 tau was higher in AD compared to controls in all CSF cohorts (<em class="a-plus-plus">p</em> < 0.001), but not N-123 tau. Decrease in cognitive performance and conversion from MCI to AD were associated with increased baseline CSF levels of N-224 tau (<em class="a-plus-plus">p</em> < 0.0001). N-224 tau concentrations in PSP and CBS were significantly lower than in AD (<em class="a-plus-plus">p</em> < 0.0001) and did not correlate to t-tau and p-tau. In a longitudinal cohort, CSF N-224 tau levels were stable over 6 months, with no significant effect of treatment with AChE inhibitors. N-224 tau was present in NDEVs, while N-123 tau showed comparable concentrations in both vesicle types. We suggest that N-123 tau is produced both in CNS and PNS and represents a general marker of tau metabolism, while N-224 tau is neuron-specific, present in the tangles, secreted in CSF, and upregulated in AD, suggesting a link between tau cleavage and propagation, tangle pathology, and cognitive decline.</p>

Fluent Molecular Mixing of Tau Isoforms in Alzheimer's Disease Neurofibrillary Tangles.

Alzheimer's Disease Seeded Tau Forms Paired Helical Filaments Yet Lacks Seeding Potential

Alzheimer’s Disease Seeded Tau Forms Paired Helical Filaments Yet Lacks Seeding Potential

Tau molecular diversity contributes to clinical heterogeneity in Alzheimer’s disease

Multivalency drives interactions of alpha-synuclein fibrils with tau

A Two-Component Adhesive: Tau Fibrils Arise from a Combination of a Well-Defined Motif and Conformationally Flexible Interactions.

Evaluating Triggers and Enhancers of Tau Fibrillization

Novel tau fragments in cerebrospinal fluid: relation to tangle pathology and cognitive decline in Alzheimer’s disease

Synergistic Interactions Between Repeats in Tau Protein and Aβ Amyloids May Be Responsible for Accelerated Aggregation Via Polymorphic States.

Biophysical Studies of Amyloid-Binding Fluorophores to Tau AD Core Fibrils Formed without Cofactors

Reconstitution of the Alzheimer’s Disease Tau Core Structure from Recombinant Tau297–391 Yields Variable Quaternary Structures as Seen by Negative Stain and Cryo-EM

Single‐Molecule Characterization and Super‐Resolution Imaging of Alzheimer's Disease‐Relevant Tau Aggregates in Human Samples

Alzheimer disease hyperphosphorylated tau aggregates hydrophobically

Unique Pathological Tau Conformers from Alzheimer'S Brains Transmit Tau Pathology in Nontransgenic Mice

Multiscale Modeling of Macromolecular Interactions between Tau-Amylin Oligomers and Asymmetric Lipid Nanodomains That Link Alzheimer's and Diabetic Diseases

EXPLORING AV1451 BINDING THROUGH BIOCHEMICAL AND BIOPHYSICAL ANALYSIS OF PHF TAU FROM HUMAN AND TG4510 BRAINS WITH ELECTRON MICROSCOPY

Live-cell visualization of tau aggregation in human neurons

Tau filaments from multiple cases of sporadic and inherited Alzheimer’s disease adopt a common fold

Structural disorder in four-repeat Tau fibrils reveals a new mechanism for barriers to cross-seeding of Tau isoforms.

Tau (297‐391) Forms Filaments That Structurally Mimic the Core of Paired Helical Filaments in Alzheimer’s Disease Brain

Molecular Polymorphism of tau aggregates in Pick's disease